Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CPB +PST | Ann: Close of ALS Offer for PST | 15/12/09 | 0 | 736 | |||
|
|||||||
PST | Ann: Close of ALS Offer | 15/12/09 | 0 | 637 | |||
|
|||||||
CPB +PST | Ann: Change in substantial holding from CPB | 14/12/09 | 0 | 663 | |||
|
|||||||
PST | Ann: Change in substantial holding | 14/12/09 | 0 | 514 | |||
|
|||||||
CPB +PST | Ann: Change in substantial holding from CPB | 10/12/09 | 0 | 618 | |||
|
|||||||
PST | Ann: Change in substantial holding | 10/12/09 | 0 | 421 | |||
|
|||||||
PST | Ann: Suspension from Official Quotation | 09/12/09 | 0 | 484 | |||
|
|||||||
CPB +PST | Ann: Letter to S/holders - Notice of Compulsory A | 07/12/09 | 0 | 557 | |||
|
See All Discussions